Orthobiologics developer OssDsign has been awarded a contract with the U.S. Department of Veterans Affairs to provide products for an additional 100 VA hospitals nationwide, according to an April 29 report from Realtid.
The new contract is a continuation of an existing contract with Red One Medical, which identifies medical innovations for the VA and the Department of Defense.
OssDsign first entered into a distribution and pricing agreement in 2021 that has gradually been expanded. With the new contract, OssDsign will cover all VA orthopedic hospitals nationwide.
All current and retired military personnel now have access to OssDsign Catalyst, a nanosynthetic bone graft that stimulates the formation of healthy bone tissue in spinal fusion surgeries.
The Veterans Health Administration is the largest integrated healthcare system in the U.S., with nearly 1,300 healthcare facilities serving 9 million veterans across the nation.